| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
PT Royal Prima Tbk Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | Rp60.00 |
| 52 Week High | Rp117.00 |
| 52 Week Low | Rp50.00 |
| Beta | 0.17 |
| 11 Month Change | -3.23% |
| 3 Month Change | 13.21% |
| 1 Year Change | -32.58% |
| 33 Year Change | -83.33% |
| 5 Year Change | -79.87% |
| Change since IPO | -92.00% |
Recent News & Updates
Recent updates
Shareholder Returns
| PRIM | ID Healthcare | ID Market | |
|---|---|---|---|
| 7D | 0% | -1.9% | -1.3% |
| 1Y | -32.6% | 21.4% | 12.8% |
Return vs Industry: PRIM underperformed the ID Healthcare industry which returned 24% over the past year.
Return vs Market: PRIM underperformed the ID Market which returned 12.2% over the past year.
Price Volatility
| PRIM volatility | |
|---|---|
| PRIM Average Weekly Movement | 7.2% |
| Healthcare Industry Average Movement | 5.7% |
| Market Average Movement | 5.6% |
| 10% most volatile stocks in ID Market | 12.8% |
| 10% least volatile stocks in ID Market | 2.4% |
Stable Share Price: PRIM has not had significant price volatility in the past 3 months compared to the ID market.
Volatility Over Time: PRIM's weekly volatility (7%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2013 | 784 | Tommy Leonard | www.royalprima.com |
PT Royal Prima Tbk provides private hospital services in Indonesia. The company operates its hospitals under the Royal Prima Medan, Royal Prima Jambi, and RSU Royal Prima Marelan names. It provides health services, such as emergency, outpatient, inpatient, laboratorium, radiology, medical rehab, pharmacy, and MCU; and general surgery, internist, VCT, ICU, cardiology, urology, haemodialysis, maternity, paediatric care, endoscopy, endoscopy, cath lab, stroke centre, and trauma centre.
PT Royal Prima Tbk Fundamentals Summary
| PRIM fundamental statistics | |
|---|---|
| Market cap | Rp202.70b |
| Earnings (TTM) | -Rp6.59b |
| Revenue (TTM) | Rp297.89b |
0.7x
P/S Ratio-30.8x
P/E RatioIs PRIM overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| PRIM income statement (TTM) | |
|---|---|
| Revenue | Rp297.89b |
| Cost of Revenue | Rp219.08b |
| Gross Profit | Rp78.81b |
| Other Expenses | Rp85.40b |
| Earnings | -Rp6.59b |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -1.95 |
| Gross Margin | 26.46% |
| Net Profit Margin | -2.21% |
| Debt/Equity Ratio | 0% |
How did PRIM perform over the long term?
See historical performance and comparison